Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Batty

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to diseaseBernadette C Young, Tanya Golubchik, Elizabeth M Batty, et al.
BMJ Open|March 23, 2024
Defining the hidden burden of disease in rural communities in Bangladesh, Cambodia and Thailand: a cross-sectional household health survey protocolMeiwen Zhang, Nan Shwe Nwe Htun, Shayla Islam, et al.
F1000Research|February 3, 2016
MinION Analysis and Reference Consortium: Phase 1 data release and analysisCamilla L C Ip, Matthew Loose, John R Tyson, et al.
Mbio|March 24, 2016
Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131Nicole Stoesser, Anna E Sheppard, Louise Pankhurst, et al.
The Lancet. Infectious Diseases|April 27, 2024
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, et al.
Wellcome Open Research|April 30, 2026
Acrobatics for Antibiotics: Exploring circus-based engagement on community practices surrounding antimicrobial resistance in CambodiaRashaad Wijntuin, Moul Vanna, Thyl Miliya, et al.
BMJ Open|September 4, 2025
Influenza and respiratory syncytial virus dynamics in Lao PDR during the COVID-19 pandemic: a hospital-based surveillance studyKoukeo Phommasone, Danoy Chommanam, Nathaniel C Christy, et al.
The Lancet. Infectious Diseases|October 13, 2025
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, Phrutsamon Wongnak, et al.
The Lancet. Infectious Diseases|October 1, 2023
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, James A Watson, et al.
The Journal of Infectious Diseases|July 20, 2023
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)Podjanee Jittamala, William H K Schilling, James A Watson, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to diseaseBernadette C Young, Tanya Golubchik, Elizabeth M Batty, et al.
BMJ Open|March 23, 2024
Defining the hidden burden of disease in rural communities in Bangladesh, Cambodia and Thailand: a cross-sectional household health survey protocolMeiwen Zhang, Nan Shwe Nwe Htun, Shayla Islam, et al.
F1000Research|February 3, 2016
MinION Analysis and Reference Consortium: Phase 1 data release and analysisCamilla L C Ip, Matthew Loose, John R Tyson, et al.
Mbio|March 24, 2016
Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131Nicole Stoesser, Anna E Sheppard, Louise Pankhurst, et al.
The Lancet. Infectious Diseases|April 27, 2024
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, et al.
Wellcome Open Research|April 30, 2026
Acrobatics for Antibiotics: Exploring circus-based engagement on community practices surrounding antimicrobial resistance in CambodiaRashaad Wijntuin, Moul Vanna, Thyl Miliya, et al.
BMJ Open|September 4, 2025
Influenza and respiratory syncytial virus dynamics in Lao PDR during the COVID-19 pandemic: a hospital-based surveillance studyKoukeo Phommasone, Danoy Chommanam, Nathaniel C Christy, et al.
The Lancet. Infectious Diseases|October 13, 2025
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, Phrutsamon Wongnak, et al.
The Lancet. Infectious Diseases|October 1, 2023
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, James A Watson, et al.
The Journal of Infectious Diseases|July 20, 2023
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)Podjanee Jittamala, William H K Schilling, James A Watson, et al.
Pageof 12